Cephalosporin-derived inhibitors of β-Lactamase. Part 4: The C3 substituent
Authors:
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (12) , 1663-1666
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhibition of Class C β-Lactamases: Structure of a Reaction Intermediate with a Cephem Sulfone,Biochemistry, 2001
- New -Lactamases in Gram-Negative Bacteria: Diversity and Impact on the Selection of Antimicrobial TherapyClinical Infectious Diseases, 2001
- β -Lactamases: which ones are clinically important?Drug Resistance Updates, 2000
- The synthesis and evaluation of 3-substituted-7-(alkylidene)cephalosporin sulfones as β-lactamase inhibitorsBioorganic & Medicinal Chemistry Letters, 2000
- How β-Lactamases Have Driven Pharmaceutical Drug Discovery1998
- Cephalosporin Substrate Specificity Determinants of TEM-1 β-LactamaseJournal of Biological Chemistry, 1997
- Introduction1997
- Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam AntibioticsClinical Infectious Diseases, 1997
- Synthesis and Biological Activity of 7-AlkylidenecephemsJournal of Medicinal Chemistry, 1995
- The structure of β-lactamasesPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980